Triclabendazole progress report, 2005-2009: An advancement of learning?

Journal of Helminthology

Volumn 83, Issue 2, 2009, Pages 139-150

  Fairweather, I ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABAMECTIN; ALBENDAZOLE; ANTIPARASITIC AGENT; ARTEETHER; ARTEMETHER; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTESUNATE; CARBAMIC ACID DERIVATIVE; CLORSULON; CLOSANTEL; DIHYDROARTEMISININ; GENISTEIN; HERBACEOUS AGENT; IVERMECTIN; KETOCONAZOLE; LEVAMISOLE; LUXABENDAZOLE; NITROXINIL; OXFENDAZOLE; OXYCLOZANIDE; OZ 277; OZ 78; PIPERONYL BUTOXIDE; PROPOLIS; THIAMAZOLE; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

DRUG ABSORPTION; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG RESEARCH; DRUG TRANSFORMATION; DRUG UPTAKE; FASCIOLA HEPATICA; FASCIOLIASIS; HUMAN; NONHUMAN; PARAGONIMIASIS; PHARMACODYNAMICS; PLASMA CONCENTRATION-TIME CURVE; REVIEW;

ANIMALS; ANTHELMINTICS; BENZIMIDAZOLES; CATTLE; CATTLE DISEASES; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FASCIOLA HEPATICA; FASCIOLIASIS; HUMANS; PLANT EXTRACTS; SHEEP; SHEEP DISEASES;

FASCIOLA HEPATICA;

EID: 70350568141     PISSN: 0022149X     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0022149X09321173     Document Type: Review

References (117)

1. Akhtar, M.S., Iqbal, Z., Khan, M.N. & Lateef, M. (2000) Anthelmintic activity of medicinal plants with particular reference to their use in animals in the Indo-Pakistan subcontinent. Small Ruminant Research 38, 99-107.
2. Albonico, M. (2003) Methods to sustain drug efficacy in helminth control programmes. Acta Tropica 86, 233-242.
3. Alvarez, L.I., Solana, H.D., Mottier, M.L., Virkel, G.L., Fairweather, I. & Lanusse, C.E. (2005) Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes. Parasitology 131, 501-510.
4. Alvarez, A.I., Merino, G., Molina, A.J., Pulido, M.M., McKellar, Q.A. & Prieto, J.G. (2006) Role of ABC transporters in veterinary drug research and parasite resistance. Current Drug Delivery 3, 199-206.
5. Alvarez-Sánchez, M.A., Mainar-Jaime, R.C., Pérez- García, J. & Rojo-Vázquez, F.A. (2006) Resistance of Fasciola hepatica to triclabendazole in sheep in Spain. Veterinary Record 159, 424-425.
6. Alvinerie, M., Dupuy, J., Eeckhoutte, C. & Sutra, J.F. (1999) Enhanced absorption of pour-on ivermectin formulation in rats by co-administration of the multidrug-resistant-reversing agent verapamil. Parasitology Research 85, 920-922.
7. Anthony, J.-P., Fyfe, L. & Smith, H. (2005) Plant active components - a resource for antiparasitic agents? Trends in Parasitology 21, 462-468.
8. Ballent, M., Lifschitz, A., Virkel, G., Sallovitz, J. & Lanusse, C. (2006) Modulation of the P-glycoproteinmediated intestinal secretion of ivermectin: in vitro and in vivo assessments. Drug Metabolism and Disposition 34, 457-463.
9. Ballent, M., Lifschitz, A., Virkel, G., Sallovitz, J. & Lanusse, C. (2007) Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazolemediated changes on gastrointestinal disposition. Journal of Veterinary Pharmacology and Therapeutics 30, 242-248.
10. Barduagni, P., Hassanein, Y., Mohamed, M., El Wakeel, A., El Sayed, M., Hallaj, Z. & Curtale, F. (2008) Use of triclabendazole for treatment of patients co-infected by Fasciola spp. and S. mansoni in Behera Governate, Egypt. Parasitology Research 102, 631-633.
11. Barnes, E.H., Dobson, R.J. & Barger, I.A. (1995) Worm control and anthelmintic resistance: adventures with a model. Parasitology Today 11, 56-63.
12. Benchaoui, H. & McKellar, Q.A. (1996) Interaction between fenbendazole and piperonyl butoxide: pharmacokinetic and pharmacodynamic implications. Journal of Pharmacy and Pharmacology 48, 753-759.
13. Bennet, E.V., Behm, C., Bryant, C.&Chevis, R.A.F. (1980) Synergistic action of mebendazole and levamisole in the treatment of a benzimidazole- resistant Haemonchus contortus in sheep. Veterinary Parasitology 7, 207-214.
14. Borgsteede, F.H.M., Moll, L., Vellema, P. & Gaasenbeek, C.P.H. (2005) Lack of reversion in triclabendazoleresistant Fasciola hepatica. Veterinary Record 156, 350-351.
15. Borstnik, K., Paik, I.-H., Shapiro, T.A. & Posner, G.H. (2002) Antimalarial chemotherapeutic peroxides: artemisinin, yinghaosu A and related compounds. International Journal for Parasitology 32, 1661-1667.
16. Büscher, G., Bowen, F.L., Strong, M.B. & Crowfoot, P.D. (1999) Efficacy of triclabendazole, its metabolites and other compounds in sheep. 17th International Conference of the WAAVP, Copenhagen, 15-19 August, abstract c7.40.
17. Calvopinã, M., Guderian, R.H., Paredes, W. & Cooper, P.J. (2003) Comparison of two single-day regimens of triclabendazole for the treatment of human pulmonary paragonimiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 451-454.
18. Coles, G.C. & Stafford, K.A. (2001) Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica. Veterinary Record 148, 723-724.
19. Coles, G.C., Rhodes, A.C. & Stafford, K.A. (2000) The activity of closantel against adult triclabendazoleresistant Fasciola hepatica. Veterinary Record 146, 504.
20. Crump, A. (2006) New medicines from nature's armamentarium. Trends in Parasitology 22, 51-54.
21. Curtale, F. (2006) Treatment of fascioliasis in human infections: a reply. Transactions of the Royal Society of Tropical Medicine and Hygiene 100, 187-188.
22. Curtale, F. (2008) Treatment of human fascioliasis with triclabendazole: good news. Transactions of the Royal Society of Tropical Medicine and Hygiene 102, 508.
23. Curtale, F., Hassanein, Y.A.E.W. & Savioli, L. (2005) Control of human fascioliasis by selective chemotherapy: design, cost and effect of the first public health, school-based intervention implemented in endemic areas of the Nile Delta, Egypt. Transactions of the Royal Society of Tropical Medicine and Hygiene 99, 599-609.
24. Das, B., Tandon, V. & Saha, N. (2007) Genistein from Flemingia vestita (Fabaceae) enhances NO and its mediator (cGMP) production in a cestode parasite, Raillietina echinobothridia. Parasitology 134, 1457-1463.
25. Das, B., Tandon, V., Lyndem, L.L., Gray, A.I. & Ferro, V.A. (2009) Phytochemicals from Flemingia vestita (Fabaceae) and Stephania glabra (Menispermeaceae) alter cGMP concentration in the cestode Raillietina echinobothrida. Comparative Biochemistry and Physiology part C, 149, 397-403.
26. Devine, C., Brennan, G.P., Lanusse, C.E., Alvarez, L.I., Trudgett, A., Hoey, E. & Fairweather, I. (2009) Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica. Parasitology 136, 183-192.
27. Elard, L., Sauve, C. & Humbert, J.F. (1998) Fitness of benzimidazole-resistant and -susceptible worms of Teladorsagia circumcincta, a nematode parasite of small ruminants. Parasitology 117, 571-578.
28. El-Tantawy, W.H., Salem, H.F. & Mohammed Safwat, N.A.S. (2007) Effect of fascioliasis on the pharmacokinetic parameters of triclabendazole in human subjects. Pharmacy World and Science 29, 190-198.
29. Fairweather, I. (2005) Triclabendazole: new skills to unravel an old(ish) enigma. Journal of Helminthology 79, 227-234.
30. Fairweather, I. & Boray, J.C. (1999) Fasciolicides: efficacy, actions, resistance and its management. Veterinary Journal 158, 81-112.
31. Fairweather, I., Meaney, M., Savage, J., Brennan, G., Hoey, E. & Trudgett, A. (2008) The role of drug efflux pumps in the development of resistance to triclabendazole in Fasciola hepatica. Xth European Multicolloquium of Parasitology (EMOP X), Paris, August, abstract SY21/01-03.
32. Fetterer, R.H. (1986) The effect of albendazole and triclabendazole on colchicine binding in the liver fluke Fasciola hepatica. Journal of Veterinary Pharmacology and Therapeutics 9, 49-54.
33. Ghisi, M., Kaminsky, R. & Mäser, P. (2007) Phenotyping and genotyping of Haemonchus contortus isolates reveals a new putative candidate mutation for benzimidazole resistance in nematodes. Veterinary Parasitology 144, 313-320.
34. Halferty, L., Brennan, G.P., Hanna, R.E.B., Edgar, H.W., Meaney, M., McConville, M., Trudgett, A., Hoey, L. & Fairweather, I. (2008) Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole. Veterinary Parasitology 155, 49-58.
35. Halferty, L., Brennan, G.P., Trudgett, A., Hoey, L. & Fairweather, I. (2009) Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica. Veterinary Parasitology 159, 126-138.
36. Hammond, J.A., Fielding, D. & Bishop, S.C. (1997) Prospects for plant anthelmintics in tropical veterinary medicine. Veterinary Research Communications 21, 213-228.
37. Hanna, R.E.B., Edgar, H., Moffett, D., McConnell, S., Fairweather, I., Brennan, G.P., Trudgett, A., Hoey, E.M., Cromie, L., Taylor, S.M. & Daniel, R. (2008) Fasciola hepatica: histology of the testis in eggproducing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts. Veterinary Parasitology 157, 222-234.
38. Hegazi, A.G., Abd El Hady, F.K. & Shalaby, H.A. (2007a) An in vitro effect of propolis on adult worms of Fasciola gigantica. Veterinary Parasitology 144, 279-286.
39. Hegazi, A.G., Abd El Hady, F.K. & Shalaby, H.A. (2007b) Inhibitory effect of Egyptian propolis on Fasciola hepatica eggs with reference to its effect on Clostridium oedematiens and correlation to chemical composition. Pakistan Journal of Biological Sciences 10, 3295-3305.
40. Hennessy, D.R., Lacey, E., Steel, J.W. & Prichard, R.K. (1987) The kinetics of triclabendazole disposition in sheep. Journal of Veterinary Pharmacology and Therapeutics 10, 64-72.
41. Hien, T.T., Truong, N.T., Minh, N.H., Dat, H.D., Dung, N.T., Hue, N.T., Dung, T.K., Tuan, P.Q., Campbell, J.I., Farrar, J.J. & Day, J.N. (2008) A randomised controlled pilot study of artesunate versus triclabendazole for human fascioliasis in Central Vietnam. American Journal of Tropical Medicine and Hygiene 78, 388-392.
42. Higashi, K.O. & de Castro, S.L. (1994) Propolis extracts are effective against Trypanosoma cruzi and have an impact on its interaction with host cells. Journal of Ethnopharmacology 43, 149-155.
43. Hopkins, T.J.&Gyr, P. (1991) Synergismof a combination of febantel and pyrantel emboate against Ancylostoma caninum on dogs. Veterinary Medical Review 61, 3-9.
44. Iqbal, Z., Akhtar, M.S., Sindhu, Z., Khan, M. & Jabbar, A. (2003) Herbal dewormers in livestock - a traditional therapy. International Journal of Agriculture and Biology 2, 199-206.
45. Kayser, O., Kiderlen, A.F. & Croft, S. (2003) Natural products as antiparasitic drugs. Parasitology Research 90, S55-S62.
46. Keiser, J. & Morson, G. (2008a) Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether. Experimental Parasitology 118, 228-237.
47. Keiser, J. & Morson, G. (2008b) Fasciola hepatica: surface tegumental responses to in vitro and in vivo treatment with the experimental fasciolicide OZ78. Experimental Parasitology 119, 87-93.
48. Keiser, J. & Utzinger, J. (2007a) Food-borne trematodiasis: current chemotherapy and advances with artemisinins and synthetic trioxolanes. Trends in Parasitology 23, 555-562.
49. Keiser, J. & Utzinger, J. (2007b) Artemisinins and synthetic trioxolanes in the treatment of helminth infections. Current Opinion in Infectious Diseases 20, 605-612.
50. Keiser, J., Engels, D., Buscher, G. & Utzinger, J. (2005) Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opinion in Investigational Drugs 14, 1513-1526.
51. Keiser, J., Xiao, S.-H., Jian, X., Chang, Z.-S., Odematt, P., Tesana, S., Tanner, M. & Utzinger, J. (2006a) Effect of artesunate and artemether against Clonorchis sinensis and Opisthorchis viverrini in rodent models. International Journal of Antimicrobial Agents 28, 370-373.
52. Keiser, J., Brun, R., Fried, B. & Utzinger, J. (2006b) Trematocidal activity of praziquantel and artemisinin derivatives: in vitro and in vivo investigations on adult Echinostoma caproni. Antimicrobial Agents and Chemotherapy 50, 803-805.
53. Keiser, J., Utzinger, J., Tanner, M., Dong, Y. & Vennerstrom, J.L. (2006c) The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica. Journal of Antimicrobial Chemotherapy 58, 1193-1197.
54. Keiser, J., Shu-Hua, X., Tanner,M. & Utzinger, J. (2006d) Artesunate and artemether are effective fasciolicides in the rat model and in vitro. Journal of Antimicrobial Chemotherapy 57, 1139-1145.
55. Keiser, J., Utzinger, J., Vennerstrom, J.L., Dong, Y., Brennan, G.P. & Fairweather, I. (2007a) Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica. Transactions of the Royal Society of Tropical Medicine and Hygiene 101, 1219-1222.
56. Keiser, J., Shu-Hua, X., Chollet, J., Tanner, M. & Utzinger, J. (2007b) Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis and Opisthorchis viverrini. Antimicrobial Agents and Chemotherapy 51, 1096-1098.
57. Keiser, J., Xiao, S.H., Dong, Y., Utzinger, J. & Vennerstrom, J.L. (2007c) Clonorchicidal properties of the synthetic trioxolane OZ78. Journal of Parasitology 93, 1208-1213.
58. Kelly, J.D., Whitlock, H.V., Thompson, H.V., Hall, C.A., Campbell, N.J., Martin, I.C.A. & Lejambre, L.F. (1978) Physiological characteristics of the free-living and parasitic stages of strains of Haemonchus contortus susceptible or resistant to benzimidazole anthelmintics. Research in Veterinary Science 25, 376-385.
59. Kerboeuf, D., Blackhall, W., Kaminsky, R. & von Samson-Himmelstjerna, G. (2003) P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance. International Journal of Antimicrobial Agents 22, 332-346.
60. Koko, W.S., Galal, M. & Khalid, H.S. (2000) Fasciolicidal efficacy of Albizia anthelmintica and Balanites aegyptiaca compared with albendazole. Journal of Ethnopharmacology 71, 247-252.
61. Lanusse, C.E. & Prichard, R.K. (1991) Enhancement of the plasma concentration of albendazole sulphoxide in sheep following coadministration of parenteral netobimin and liver oxidase inhibitors. Research in Veterinary Science 51, 306-312.
62. Lanusse, C.E. & Prichard, R.K. (1992) Methimazole increases the plasma concentrations of the albendazole metabolites of netobimin in sheep. Biopharmaceutics and Drug Disposition 13, 95-103.
63. Lespine, A., Alvinerie, M., Vercruysse, J., Prichard, R. & Geldhof, P. (2008) ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics. Trends in Parasitology 24, 293-298.
64. Li, Y. & Wu, Y.-L. (2003) An over four millennium story behind qinghaosu (artemisinin) - a fantastic antimalarial drug from a traditional Chinese herb. Current Medicinal Chemistry 10, 2197-2230.
65. Lifschitz, A., Virkel, G., Ballent, M., Sallovitz, J. & Lanusse, C. (2009) Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction. Veterinary Journal, in press.
66. López-Garcia, M.L., Torrado, S., Torrado, S., Martinez, A.R. & Bolás, F. (1998) Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the doseregime. Veterinary Parasitology 75, 209-219.
67. Maingi, N., Scott, M.E. & Prichard, R.K. (1990) Effect of selection pressure for thiabendazole resistance on fitness of Haemonchus contortus in sheep. Parasitology 100, 327-335.
68. Mas-Coma, S., Bargues, M.D. & Valero, M.A. (2005) Fascioliasis and other plant-borne trematode zoonoses. International Journal for Parasitology 35, 1255-1278.
69. McConville, M., Brennan, G.P., McCoy, M., Castillo, R., Hernández-Campos, A. & Fairweather, I. (2006) Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha. Parasitology 133, 195-208.
70. McConville, M., Brennan, G.P., McCoy, M., Castillo, R., Hernández-Campos, A., Ibarra, F. & Fairweather, I. (2007) Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha. Parasitology Research 100, 365-377.
71. McConville, M., Brennan, G.P., Flanagan, A., Edgar, H.W.J., McCoy, M., Castillo, R., Hernández-Campos, A. & Fairweather, I. (2008) Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha. Veterinary Parasitology 153, 52-64.
72. McConville, M., Brennan, G.P., Flanagan, A., Edgar, H.W.J., Hanna, R.E.B., McCoy, M., Gordon, A.W., Castillo, R., Hernández-Campos, A. & Fairweather, I. (2009a) An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica. Veterinary Parasitology, in press.
73. McConville, M., Brennan, G.P., Flanagan, A., Edgar, H.W.J., Castillo, R., Hernández-Campos, A. & Fairweather, I. (2009b) TEM ultrastructural changes to the tegumental system and the gastrodermal cells in mature flukes following in vivo treatment with the experimental fasciolicide, compound alpha. Parasitology, in press.
74. McCoy, M.A., Fairweather, I., Brennan, G.P., Kenny, J.M. & Forbes, A.B. (2005) The efficacy of nitroxynil and triclabendazole administered synchronously against juvenile triclabendazole-resistant Fasciola hepatica in sheep. Research in Veterinary Science 78, 33.
75. McKinstry, B., Brennan, G.P., Halferty, L., Forbes, A.B. & Fairweather, I. (2007) Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax). Parasitology Research 101, 929-941.
76. McKinstry, B., Halferty, L., Brennan, G.P. & Fairweather, I. (2009) Morphological response of triclabendazole-resistant isolates of Fasciola hepatica to treatment in vitro with nitroxynil (Trodax). Parasitology Research 104, 645-655.
77. Meaney, M., Allister, J., McKinstry, B., McLaughlin, K., Brennan, G.P., Forbes, A.B. & Fairweather, I. (2006) Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke. Parasitology Research 99, 609-621.
78. Meaney, M., Allister, J., McKinstry, B., McLauglin, K., Brennan, G.P., Forbes, A.B. & Fairweather, I. (2007) Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke. Parasitology Research 100, 1091-1104.
79. Merino, G., Molina, A.J., Garcia, J.L., Pulido, M.M., Prieto, J.G. & Alvarez, A.I. (2003) Intestinal elimination of albendazole sulfoxide: pharmacokinetic effects of inhibitors. International Journal of Pharmaceutics 263, 123-132.
80. Mestorino, N., Formentini, E.A., Lucas, M.F., Fernandez, C., Modamio, P., Marinõ Hernández, E. & Errecalde, J.O. (2008) Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide. Veterinary Research Communications 32, 21-33.
81. Molento, M.B. & Prichard, R.K. (1999) Effects of the multidrug-reversing agents verapamil and CL 347, 099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds. Parasitology Research 85, 1007-1011.
82. Moll, L., Gaasenbeek, C.P.H., Vellema, P. & Borgsteede, F.H.M. (2000) Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in the Netherlands. Veterinary Parasitology 91, 153-158.
83. Mottier, L., Virkel, G., Solana, H., Alvarez, L., Salles, J.& Lanusse, C. (2004) Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidised metabolites into Fasciola hepatica. Xenobiotica 34, 1043-1047.
84. Mottier, L., Alvarez, L., Ceballos, L. & Lanusse, C. (2006a) Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics. Experimental Parasitology 113, 49-57.
85. Mottier, L., Alvarez, L., Fairweather, I. & Lanusse, C. (2006b) Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect. Journal of Parasitology 92, 1355-1360.
86. O'Neill, J.F., Johnston, R.C., Halferty, L., Brennan, G.P., Keiser, J.&Fairweather, I. (2009)Adult triclabendazoleresistant Fasciola hepatica: morphological responses to in vivo treatment with artemether in the rat model. Journal of Helminthology this issue.
87. Ramírez, N., Mayet, L., Del Rivero, L., Ibarra-Velarde, F., Castillo, R., Hernández-Campos, A. & Jung-Cook, H. (2009) Pharmacokinetic behaviour in sheep and cattle of 5-chloro-2-(methylthio)-6-(1- naphthyloxy)-1H-benzimidazole, a new fasciolicide agent. Journal of Veterinary Pharmacology and Therapeutics, in press.
88. Rao, R.R. (1981) Ethnobotany of Meghalaya: medicinal plants used by Khasi and Garo tribes. Economic Botany 35, 4-9.
89. Reyes, P.M., Ibarra, V.F., Vera, M.Y., Cantó , A.G., Hernández, A., Hernández, C.A., Castillo, R. & Villa, M.A. (2008) Paramphistomicidal efficacy of an experimental compound in sheep. Parasitology Research 102, 705-708.
90. Rivero, L.M., Jung, H., Castillo, R. & Hernández-Campos, A. (1998) High-performance liquid chromatographic assay for a new fasciolicide agent, a-BIOF10, in biological fluids. Journal of Chromatography B 712, 237-241.
91. Robinson, M.W., Trudgett, A., Hoey, E.M. & Fairweather, I. (2002) Triclabendazole-resistant Fasciola hepatica: b-tubulin and response to in vitro treatment with triclabendazole. Parasitology 124, 325-338.
92. Robinson, M.W., Lawson, J., Trudgett, A., Hoey, E.M. & Fairweather, I. (2004a) The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitology Research 92, 205-210.
93. Robinson, M.W., McFerran, N., Trudgett, A., Hoey, L. & Fairweather, I. (2004b) A possible model of benzimidazole binding to b-tubulin disclosed by invoking an inter-domain movement. Journal of Molecular Graphics and Modelling 23, 275-284.
94. Roy, B. & Tandon, V. (1999) Flukicidal activity of Alpinia nigra (Zingiberaceae) against the trematode, Fasciolopsis buski, in humans. Biomedical Letters 60, 23-29.
95. Ryan, L.A., Hoey, E., Trudgett, A., Fairweather, I., Fuchs, M., Robinson, M.W., Chambers, E., Timson, D., Ryan, E., Fetwell, T., Ivens, A., Bentley, G. & Johnston, D. (2008) Fasciola hepatica expresses multiple a- and b-tubulin isotypes. Molecular and Biochemical Parasitology 159, 73-78.
96. Sánchez, S., Small, J., Jones, D. & McKellar, Q.A. (2002) Plasma achiral and chiral pharmacokinetic behaviour of intravenous oxfendazole co-administered with piperonyl butoxide in sheep. Journal of Veterinary Pharmacology and Therapeutics 25, 7-13.
97. Sangster, N.C. (2001) Managing parasiticide resistance. Veterinary Parasitology 98, 89-109.
98. Shiramizu, K., Tuchida, T. & Anu, M. (1993) The anthelmintic effect on bovine fascioliasis of a crude preparation containing the root of Matteuccia orietalis. Journal of the Japan Veterinary Medical Association 46, 561-564.
99. Shoop, W.L., Ostlind, D.A., Rohrer, S.P., Mickle, G., Haines,H.W., Michael, B.F.,Mrozik, H.&Fisher, M.H. (1995) Avermectins and Milbemycins against Fasciola hepatica: in vivo drug efficacy and in vitro receptor binding. International Journal for Parasitology 25, 923-927.
100. Shu-Hua, X., Jian, X., Tanner, M., Yong-Nian, Z., Keiser, J., Utzinger, J. & Hui-Qiang, Q. (2008) Artemether, artesunate, praziquantel and tribendimidine administered singly at different dosages against Clonorchis sinensis: a comparative in vivo study. Acta Tropica 106, 54-59.
101. Spicher, M., Roethlisberger, C., Lany, C., Stadelmann, B., Keiser, J., Ortega-Mora, L.M., Gottstein, B. & Hemphill, A. (2008) In vitro and in vivo treatments of Echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives. Antimicrobial Agents and Chemotherapy 52, 3447-3450.
102. Stepek, G., Lowe, A.E., Buttle, D.J., Duce, I.R.&Behnke, J.M. (2007) In vitro anthelmintic effects of cysteine proteinases from plants against intestinal helminths of rodents. Journal of Helminthology 81, 353-360.
103. Tagboto, S. & Townson, S. (2001) Antiparasitic properties of medicinal plants and other naturally occurring products. Advances in Parasitology 50, 198-295.
104. Toner, E., Brennan, G.P., Wells, K., McGeown, J.G. & Fairweather, I. (2008) Physiological and morphological effects of genistein against the liver fluke, Fasciola hepatica. Parasitology 135, 1189-1203.
105. Toner, E., McConvery, F., Brennan, G.P., Meaney, M. & Fairweather, I. (2009) A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica. Parasitology, in press.
106. Utzinger, J. & Keiser, J. (2004) Schistosomiasis and soiltransmitted helminthiasis: common drugs for treatment and control. Expert Opinion on Pharmacotherapy 5, 263-285.
107. Utzinger, J., Xiao, S.-H., Tanner, M. & Keiser, J. (2007) Artemisinins for schistosomiasis and beyond. Current Opinion in Investigational Drugs 8, 105-116.
108. Vennerstrom, J.L., Arbe-Barnes, S., Brun, R., Charman, S.A., Chiu, F.C.K., Chollet, J., Dong, Y., Dorn, A., Hunziker,D.,Matile,H.,McIntosh,K., Padmanilayam, M., Tomas, J.S., Scheurer, C., Scorneaux, B., Tang, Y., Urwyler, H., Wittlin, S. & Charman, W.N. (2004) Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 430, 900-904.
109. Virkel, G., Lifschitz, A., Sallovitz, J., Pis, A. & Lanusse, C. (2006) Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep. Journal of Veterinary Pharmacology and Therapeutics 29, 213-223.
110. Virkel,G., Lifschitz, A., Sallovitz, J., Ballent,M., Scarcella, S. & Lanusse, C. (2009) Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep. Journal of Veterinary Pharmacology and Therapeutics 32, 79-86.
111. Walker, S.M., Hoey, E., Fletcher, H., Brennan, G., Fairweather, I. & Trudgett, A. (2006) Stage-specific differences in fecundity over the life-cycle of two characterized isolates of the liver fluke, Fasciola hepatica. Parasitology 133, 209-216.
112. WHO(2007) Report of theWHO Informal Meeting on use of triclabendazole in fascioliasis control, held at WHO Headquarters, Geneva, Switzerland, October 2006. 39 pp. Geneva, WHO.
113. Wolstenholme, A.J., Fairweather, I., Prichard, R., von Samson-Himmelstjerna, G. & Sangster, N.C. (2004) Drug resistance in veterinary helminths. Trends in Parasitology 20, 469-476.
114. Woodrow, C.J., Haynes, R.K. & Krishna, S. (2005) Artemisinins. Postgraduate Medical Journal 81, 71-78.
115. Xiao, S.-H. (2005) Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. Acta Tropica 96, 153-167.
116. Xiao, S.-H.,Wu, Y.-L., Tanner, M.,Wu,W.-M., Utzinger, J., Mei, J.-Y., Scorneaux, B., Chollet, J. & Zhai, Z. (2003) Schistosoma japonicum: in vitro effects of artemether combined with haemin depend on cultivation media and appraisal of artemether products appearing in the media. Parasitology Research 89, 459-466.
117. Xue, J., Utzinger, J., Zhang, Y.-N., Tanner, M., Keiser, J. & Xiao, S.-H. (2008) Artemether and tribendimidine lack activity in experimemtal treatment of Paragonimus westermani in the dog. Parasitology Research 102, 537-540.